Literature DB >> 7729777

The polybacterial lysate Olimunostim modulates lymphocyte function in vitro and restores depressed cellular immunity in vivo.

M Petrek1, E Weigl, M Ordeltová.   

Abstract

Immunobiological activity of the polybacterial lysate Olimunostim (P. acnes, K. pneumoniae, S. aureus) was examined by investigating its effects on murine lymphocytes. When added to in vitro lymphocyte cultures, Olimunostim induced interleukin-2 (IL-2) biological activity (in a 2-d culture) and subsequently potentiated lymphocyte proliferation (on day 3); the latter effect was dependent on the presence of adherent cells. In vivo, significant enhancement of lymphocyte reactivity to T-mitogens and increase of CD4+ helper-inducer T lymphocytes were observed 3 d after a subcutaneous application of Olimunostim to mice with cellular immune deficiency. These results confirm the modulatory properties of Olimunostim towards lymphocytes both in vitro and in vivo, which may form a basis for its clinical application.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7729777     DOI: 10.1007/bf02814452

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  13 in total

1.  Lymphocyte proliferation and T-lymphocyte subsets during experimental immunomodulation of Balb/C mice by Olimunostim.

Authors:  M Petrek; E Weigl; M Hajdúch; D Tomanová; A Spidlová
Journal:  Acta Univ Palacki Olomuc Fac Med       Date:  1992

2.  Immune modulation exerted by thymic humoral factor (THF-gamma 2), on T-cell subsets and IL-2 production of umbilical cord blood lymphocytes.

Authors:  H Ben-Hur; M Pecht; L Netzer; R Borenstein; I Blickstein; Y Burstein; N Trainin
Journal:  Immunopharmacol Immunotoxicol       Date:  1990       Impact factor: 2.730

3.  Biological activity of bacterial surface components: bacterial extracts and defined bacterial cell wall components as immunomodulators.

Authors:  W G Bessler; B Kleine; C Martinez Alonso; L Biesert; M Strecker; K H Wiesmüller; J Metzger; G Jung
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 4.  Immunomodulators isolated from microorganisms.

Authors:  Z Vanĕk; J Matĕjů; E Curdová
Journal:  Folia Microbiol (Praha)       Date:  1991       Impact factor: 2.099

5.  Preclinical screening and analysis of the immunotoxic and immunomodulatory activity using a multiple immunoassay (MIA) in mice.

Authors:  K Nouza; K Sůla; R Dvorák; M Svobodová; J Müller; E Sobotková
Journal:  Int J Immunopharmacol       Date:  1990

6.  Activation of natural killer cells and cytokine production in man by bacterial extracts.

Authors:  J Wybran; M Libin; L Schandene
Journal:  Immunopharmacol Immunotoxicol       Date:  1989       Impact factor: 2.730

7.  Multistep scheme for testing immunomodulatory substances.

Authors:  A Macela; H Kovárová; J Stulík; M Ferencík; P Propper; E Hosková
Journal:  Bratisl Lek Listy       Date:  1989-10       Impact factor: 1.278

8.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

9.  Prevention of bacterial respiratory infection by an association of bacterial ribosomes and membranous proteoglycans. 2. Objective assessment of the response and of the immunological stimulation.

Authors:  F B Michel; L Dussourd d'Hinterland; A M Pinel; R Guendon; A J Guerrero; M Moutou; J P Bansard
Journal:  Arzneimittelforschung       Date:  1980

10.  Bacteria of human physiological microflora liberate immunomodulating peptides.

Authors:  G Pulverer; J Beuth; W Roszkowski; H Burrichter; K Roszkowski; A Yassin; H L Ko; J Jeljaszewicz
Journal:  Zentralbl Bakteriol       Date:  1990-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.